Long-Term Efficacy and Safety of Stapokibart in Adults with Moderate-to-Severe Atopic Dermatitis: An Open-Label Extension, Nonrandomized Clinical TrialYan Zhao, Jing Li, Bin Yang et al.|BioDrugs|2024Cited by 16
51194 Efficacy and Safety of MG-K10 in Adult Patients with Moderate-to-Severe Atopic Dermatitis: Results From The Phase 2 StudyJinhua Xu, Heng Gu, Yangfeng Yangfeng Ding et al.|Journal of the American Academy of Dermatology|2024Cited by 1
62576 MG-K10 significantly improved clinical signs across all anatomical regions in adults with moderate-to-severe atopic dermatitisJinhua Xu, Heng Gu, Litao Zhang et al.|Journal of the American Academy of Dermatology|2025Cited by 0